Product Description
Sarecycline is a new oral tetracycline antibiotic recently approved by the US Food and Drug Administration. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/31462063/)
Mechanisms of Action: Protein Synthesis Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: United States
Approved Indications: None
Known Adverse Events: None
Company: Almirall
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 4: Rosacea|Dermatitis, Perioral
Phase 3: Acne Vulgaris
Phase 2: Acne Vulgaris|Ischemic Stroke
Phase 1: Healthy Volunteers
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| DIB-0601 | P4 |
Completed |
Dermatitis, Perioral |
2024-03-31 |
2024-06-26 |
Patient Enrollment|Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status |
|
| ESPRIT | P2 |
Recruiting |
Ischemic Stroke |
2023-11-01 |
2023-07-21 |
Primary Endpoints|Start Date|Treatments|Trial Status |
|
| CTR20211314 | N/A |
Completed |
Acne Vulgaris |
2023-06-26 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20222916 | N/A |
Completed |
Acne Vulgaris |
2023-04-16 |
2025-04-29 |
Patient Enrollment|Treatments |
|
| PROSES | N/A |
Completed |
Acne Vulgaris |
2022-05-04 |
2022-09-14 |
Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status |
|
| CTR20210472 | P1 |
Completed |
Healthy Volunteers |
2022-03-25 |
2025-04-29 |
Patient Enrollment|Treatments |
|
| TASER | N/A |
Completed |
Acne Vulgaris |
2021-06-24 |
2023-08-02 |
Primary Endpoints|Study Completion Date|Treatments|Trial Status |
|
| SEY1901 | P4 |
Completed |
Rosacea |
2020-09-23 |
2020-12-17 |
Primary Completion Date|Primary Endpoints|Start Date|Study Completion Date|Treatments|Trial Status |
|
| SC1401 | P3 |
Completed |
Acne Vulgaris |
2017-02-01 |
2019-03-20 |
Treatments |
|
| SC1402 | P3 |
Completed |
Acne Vulgaris |
2017-01-12 |
2019-03-20 |
Treatments |
|
| SC1401 | P3 |
Withdrawn |
Acne Vulgaris |
2016-12-01 |
2019-03-20 |
Treatments |
|
| SC1403 | P3 |
Completed |
Acne Vulgaris |
2016-08-26 |
2019-03-20 |
Treatments |
|
| PR-10411 | P2 |
Completed |
Acne Vulgaris |
2012-11-16 |
2019-03-19 |
Primary Completion Date|Start Date|Study Completion Date|Treatments |